Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for MultiCell Technologies's Days Inventory or its related term are showing as below:
MCET's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 184.66 * Ranked among companies with meaningful Days Inventory only.
MultiCell Technologies's Days Inventory
stayed the same
from Aug. 2014 (0.00) to Aug. 2015 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MultiCell Technologies's Inventory-to-Revenue for the
three
months ended in Aug. 2015 was 0.00.
MultiCell Technologies (OTCPK:MCET) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
MultiCell Technologies's Inventory Turnover for the
three
months ended in Aug. 2015 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MultiCell Technologies's Inventory to Revenue for the
three
months ended in Aug. 2015 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
MultiCell Technologies Days Inventory Related Terms
MultiCell Technologies Days Inventory Historical Data
* Premium members only.
The historical data trend for MultiCell Technologies's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MCET vs ERGO, OPLI, GLAG: Days Inventory Comparison
For the Biotechnology subindustry, MultiCell Technologies's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MultiCell Technologies Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MultiCell Technologies's Days Inventory distribution charts can be found below:
* The bar in red indicates where MultiCell Technologies's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MultiCell Technologies (MCET) has a Days Inventory of 0.00 as of Aug. 2015. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MultiCell Technologies and its competitors.
Is MultiCell Technologies' Days Inventory too high?
MultiCell Technologies' current Days Inventory is 0.00.
How does MultiCell Technologies' Days Inventory compare to ERGO and OPLI?
MultiCell Technologies' Days Inventory of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Inventory is 184.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 184.66, based on 639 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MultiCell Technologies and its competitors. For the Biotechnology industry, the median Days Inventory is 184.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MultiCell Technologies's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MultiCell Technologies stock overvalued right now?
MultiCell Technologies (MCET) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For MultiCell Technologies (MCET), the current Days Inventory is 0.00 as of Aug. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MultiCell Technologies Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and others. Its therapeutic development platform includes several patented techniques used to isolate, characterize, and differentiate stem cells from the human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor, and MDA-5 signaling. The company's medical device development platform is based on the design of a next-generation bioabsorbable stent, the Ideal BioStent, for interventional cardiology and peripheral vessel applications. All the operations are functioned within United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MCET has been successfully added to your 
